Evidence map›Paper›PMID 39258535›Full record

ReviewJournal of cellular and molecular medicine2024

Brain organoids: A new tool for modelling of neurodevelopmental disorders.

Yirizhati Aili, Nuersimanguli Maimaitiming, Zengliang Wang, Yongxin Wang

Abstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Brain organoids: A new tool for modelling of neurodevelopmental disorders.Journal of cellular and molecular medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yirizhati AiliDepartment of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China.
Nuersimanguli MaimaitimingThe Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Zengliang WangDepartment of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China.ORCID 0000-0002-8411-5678
Yongxin WangDepartment of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China.

Funding

Natural Science Foundation of Xinjiang Uygur Autonomous Region 2022D01D70Natural Science Foundation of Xinjiang Uygur Autonomous Region 20231107414
6 · The paper itself

Abstract

Neurodevelopmental disorders are mostly studied using mice as models. However, the mouse brain lacks similar cell types and structures as those of the human brain. In recent years, emergence of three-dimensional brain organoids derived from human embryonic stem cells or induced pluripotent stem cells allows for controlled monitoring and evaluation of early neurodevelopmental processes and has opened a window for studying various aspects of human brain development. However, such organoids lack original anatomical structure of the brain during maturation, and neurodevelopmental maturation processes that rely on unique cellular interactions and neural network connections are limited. Consequently, organoids are difficult to be used extensively and effectively while modelling later stages of human brain development and disease progression. To address this problem, several methods and technologies have emerged that aim to enhance the sophisticated regulation of brain organoids developmental processes through bioengineering approaches, which may alleviate some of the current limitations. This review discusses recent advances and application areas of human brain organoid culture methods, aiming to generalize optimization strategies for organoid systems, improve the ability to mimic human brain development, and enhance the application value of organoids.

Indexed as

BrainNeurodevelopmental DisordersOrganoidsAnimalsHumansInduced Pluripotent Stem CellsModels, Biologicalbrain organoidsinduced pluripotent stem cellsneurodevelopmental diseasespreclinical models

Identifiers

PMID39258535
PMCPMC11388061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.